7:30 am — 5:30 pm
San Diego
San Diego, Convention Center, , Room 23AB, CA, United States
Loading Events
Loading Events
  • This event has passed.
6:30 a.m. 7:30 a.m. Registration/Breakfast
7:30 a.m. 8:30 a.m. Session 1: Prize Abstracts
Moderator: Michael Hsieh, MD, PhD
Moderator: Jonathan C. Routh, MD
7:30 a.m. 7:37 a.m. Presence of Germ Cells in Disorders of Sex Development
7:37 a.m. 7:44 a.m. National Trends in Resource Utilization for the Management of Antenatal Hydronephrosis
7:44 a.m. 7:51 a.m. Interobserver Reliability in Interpretation of Pediatric Urodynamic Tracings
7:51 a.m. 7:58 a.m. Childhood Cancer Risk In The Siblings and Cousins Of Men With Poor Semen Quality
7:58 a.m. 8:05 a.m. HDAC8 Plays a Critical Role in Fibroblast Activation and the Pathogenesis of Renal Fibrosis Following Chronic Urinary Tract Obstruction
8:05 a.m. 8:12 a.m. Complex Epithelial Transitions Underlie the Fusion Event in Early Fetal Development of the Penile Urethra
8:12 a.m. 8:19 a.m. Urinary Proteomic Analysis for Biomarkers to Identify At-Risk Patients with Vesicoureteral Reflux
8:19 a.m. 8:30 a.m. Marked Increase in Urinary Excretion of Apolipoproteins in Children with Nephrolithiasis Associated with Hypercalciuria and Hypocitraturia
Moderator: Michael J. DiSandro, MD
Moderator: Margarett Shnorhavorian, MD
8:37 a.m. 8:44 a.m. Changes in Levels of Parental Distress After their Child with a Disorder of Sex Development Undergoes Genitoplasty
8:44 a.m. 8:51 a.m. Attitudes Toward &[Prime]Disorders of Sex Development&[Prime] Nomenclature Among Affected Individuals
8:51 a.m. 8:58 a.m. Fertility-related Care for Gender and Sex Diverse Individuals: A Provider Needs-Assessment Survey
8:58 a.m. 9:05 a.m. Gene Targeted Chromosome Microarray Analysis in Disorders of Sex Development: Uncovering Small Copy Number Variations Beneath the Surface
9:05 a.m. 9:12 a.m. Characterization of Males with Congenital Adrenal Hyperplasia Examined for the Presence of Testicular Adrenal Rest Tumors (TART)
9:12 a.m. 9:19 a.m. Predicting the Degree of Virilization in Females with Congenital Adrenal Hyperplasia (CAH) Based on Genotype
9:19 a.m. 9:26 a.m. Geographic Variation in Treatment for Patients with Disorders of Sex Development
9:26 a.m. 9:30 a.m. Cost Analysis and Clinical Outcomes of Feminizing Genitoplasty on Congenital Adrenal Hyperplasia Using a Large Scale Administrative Database
9:30 a.m. 10:25 a.m. DSD Panel: Evolving Role of Patient Advocacy (Multidisciplinary DSD Clinic, Support Groups in Car of Affected Individuals and Their Families, Social Media, Clinician as Patient Advocate)
Moderator: Jeffrey B. Campbell, MD
Panelist: Arlene Baratz, MD
Panelist: Noi Liang, MD
Panelist: Emily Quinn, MD
Panelist: Ilene Yi-Zhen Wong, MD
Moderator: Paul F. Austin, MD
Moderator: Dana A. Weiss, MD
10:45 a.m. 10:50 a.m. Role of Body Mass Index in School-Aged Children with Bladder-Bowel Dysfunction: Does Weight Predict Outcome?
10:50 a.m. 10:55 a.m. An Analysis of National Ambulatory Visits and Medication Prescribing Patterns for Pediatric Lower Urinary Tract Dysfunction, 1998-2011
10:55 a.m. 11 a.m. Efficacy and Tolerability of Solifenacin 5mg Fixed Dose in Korean Children with Newly Diagnosed Idiopathic Overactive Bladder: A Multicenter Prospective Study
11 a.m. 11:05 a.m. Combined Low Dosed Antimuscarinics for Refractory Detrusor Overactivity in Children
11:05 a.m. 11:10 a.m. Outcomes of Sacral Neuromodulation in Children with Dysfunctional Elimination Syndrome and Neurogenic Bladder
11:10 a.m. 11:15 a.m. Bladder Training Video (BTV) vs. Standard Urotherapy for Bladder and Bowel Dysfunction: A Non-Inferiority Randomized Controlled Trail (RCT)
11:15 a.m. 11:20 a.m. Does a Fully Automatic Voiding Diary Improve Patient’s Compliance and Data Accuracy? Initial Feasibility Pilot Study
11:20 a.m. 11:25 a.m. Impact of Procedural Sedation on Outcomes of Pediatric Urodynamic Testing
11:25 a.m. 11:30 a.m. The Role of Adenotonsillectomy in the Treatment of Primary Nocturnal Enuresis in Children: A Systematic Review
11:30 a.m. 11:35 a.m. Combined Laser Acupuncture and Desmopressin for Treating Resistant Cases of Monosymptomatic Nocturnal Enuresis: A Randomized Comparative Study
11:35 a.m. 11:40 a.m. Transcutaneous Electrical Nerve Stimulation: Preliminary Results of a Novel Treatment for Nocturnal Enuresis in Children
11:40 a.m. 12:15 p.m. Meredith Campbell Lecture: Mentoring
Speaker: Laurence S. Baskin, MD
12:15 p.m. 12:30 p.m. SFU Business Meeting (SFU Members Only)
1:45 p.m. 1:48 p.m. Open Newborn Pyeloplasty – Developing Your Craft and Surgical Education
Speaker: Max Maizels, MD
1:48 p.m. 2:45 p.m. SFU Panel: Prenatal Imaging
Moderator: Sean T. Corbett, MD
Panelist: Alan Bailie, MD
Panelist: Andrew Hull, MD
Moderator: George Chiang, MD
Moderator: Micah A. Jacobs, MD
2:52 p.m. 2:59 p.m. Long-term Impacts of Concomitant Posterior Urethral Valve Ablation and Bladder Neck Incision on Urinary Continence and Ejaculation
2:59 p.m. 3:06 p.m. Posterior Urethral Valves: Impact of Low Birth Weight and Preterm Delivery on the Final Renal Outcome
3:06 p.m. 3:13 p.m. Natural History and Management of Perinatally Detected Hydronephrosis, Through Long-Term Follow Up
3:13 p.m. 3:20 p.m. Isolated Low Grade Prenatally Detected Unilateral Hydronephrosis: Do We Need Long Term Follow Up?
3:20 p.m. 3:27 p.m. Association of Initial SFU Grades and UTD Risk Groups with Clinical Outcomes in Patients with Isolated Prenatal Hydronephrosis
3:27 p.m. 3:34 p.m. Prediction of Clinical Outcomes in Prenatal Hydronephrosis: What Data Can be Gleaned from Initial Diuresis Renography?
3:34 p.m. 3:41 p.m. Renal Parenchyma to Hydronephrosis Area Ratio (PHAR) is a Powerful Predictor of Future Surgical Intervention for Infants with High-Grade Antenatal Hydronephrosis
3:41 p.m. 3:45 p.m. Maternal Urinary Carbohydrate Antigen 19-9 as a Novel Biomarker for Evaluating Fetal Hydronephrosis: A Pilot Study
4:10 p.m. 4:40 p.m. SFU Lecture: Management of PUV
Speaker: Curtis A. Sheldon, MD
Moderator: John Gatti, MD
Moderator: Adam B. Hittelman, MD, PhD
4:40 p.m. 4:45 p.m. A Practice Pattern Assessment of Members of Society of Pediatric Urology for the Evaluation and Treatment of Urinary Tract Dilation
4:45 p.m. 4:50 p.m. Time to Resolution: A Prospective Evaluation from the Society for Fetal Urology (SFU) Hydronephrosis Registry
4:50 p.m. 4:55 p.m. Retroperitoneoscopic Assisted Single-Site Pyeloplasty Using EZ Access in Children: Comparison with Open Dismembered Pyeloplasty
4:55 p.m. 5 p.m. Dismembered Pyeloplasy in Infants < 6 Months With and Without External Trans-Anastomotic Nephrostent: A Prospective Randomized Study
5 p.m. 5:05 p.m. Laparoscopic Versus Open Pyeloplasty in Children: Results of a Randomized, Prospective Controlled Trial
5:05 p.m. 5:10 p.m. Enzymatically Active Heparanase Regulates Obstruction-Induced STAT3 Activation and Renal Fibrosis
5:10 p.m. 5:15 p.m. Study Of BMP-SMAD Signaling Pathway Involvement in the Etiology of Congenital Anomalies of the Kidney and Urinary Tract, Accompanied by Cryptorchidism, by Using Whole Exome Sequencing
5:15 p.m. 5:20 p.m. Impact of De Novo Vesicoureteral Reflux on Transurethral Surgery Outcomes in Pediatric Patients with Ureteroceles
5:20 p.m. 5:25 p.m. Bladder Neck Incision in Patients with Posterior Urethral Valve: Do We Need It?
5:25 p.m. 5:30 p.m. Ablation of Posterior Urethral Valves in High Risk Patients


May 6, 2016
7:30 am - 5:30 pm
Event Category: